Legend Biotech Corp (LEGN)
39.97
+0.62
(+1.58%)
USD |
NASDAQ |
Nov 14, 12:49
Legend Biotech Total Liabilities (Quarterly): 639.18M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 639.18M |
| March 31, 2024 | 611.05M |
| December 31, 2023 | 597.24M |
| September 30, 2023 | 499.70M |
| June 30, 2023 | 523.63M |
| March 31, 2023 | 556.20M |
| December 31, 2022 | 586.65M |
| June 30, 2022 | 460.11M |
| March 31, 2022 | 601.95M |
| Date | Value |
|---|---|
| December 31, 2021 | 353.52M |
| September 30, 2021 | 587.90M |
| March 31, 2021 | 408.80M |
| December 31, 2020 | 124.32M |
| September 30, 2020 | 373.74M |
| June 30, 2020 | 371.86M |
| March 31, 2020 | 380.82M |
| December 31, 2019 | 410.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
124.32M
Minimum
Dec 2020
639.18M
Maximum
Jun 2024
475.72M
Average
499.70M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 108.13B |
| Alnylam Pharmaceuticals Inc | 4.173B |
| BioCryst Pharmaceuticals Inc | 959.82M |
| Biomarin Pharmaceutical Inc | 1.438B |
| National Healthcare Corp | 575.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.798B |
| Shareholders Equity (Quarterly) | 1.159B |
| Debt to Equity Ratio | 0.2516 |
| Current Ratio | 4.841 |
| Net Debt Paydown Yield | -0.06% |